Robert Martell insider trades: Curis (CRIS) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Robert reports to the SEC
Open-market buys and sales
1 trade reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jan 23, 2019 | CRIS | ↓ Sell | 5,500 | $1.07 | $6K | Direct | Jan 25, 2019 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other CRIS insiders
Open-market trades in the last 12 months
About Robert Martell's insider trades
Robert Martell is Head of Research & Development at Curis (CRIS). Since Jan 23, 2019, Robert has reported no open-market purchases and 1 sale worth $6K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (17 filings), shares withheld for taxes (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CRIS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.